Cargando…
Effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes
We previously demonstrated that a loosely restricted 45%-carbohydrate diet led to greater reduction in hemoglobin A1c (HbA1c) compared to high-carbohydrate diets in outpatients with mild type 2 diabetes (mean HbA1c level: 7.4%) over 2 years. To determine whether good glycemic control can be achieved...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690585/ https://www.ncbi.nlm.nih.gov/pubmed/19419563 http://dx.doi.org/10.1186/1743-7075-6-21 |
_version_ | 1782167838316822528 |
---|---|
author | Haimoto, Hajime Sasakabe, Tae Wakai, Kenji Umegaki, Hiroyuki |
author_facet | Haimoto, Hajime Sasakabe, Tae Wakai, Kenji Umegaki, Hiroyuki |
author_sort | Haimoto, Hajime |
collection | PubMed |
description | We previously demonstrated that a loosely restricted 45%-carbohydrate diet led to greater reduction in hemoglobin A1c (HbA1c) compared to high-carbohydrate diets in outpatients with mild type 2 diabetes (mean HbA1c level: 7.4%) over 2 years. To determine whether good glycemic control can be achieved with a 30%-carbohydrate diet in severe type 2 diabetes, 33 outpatients (15 males, 18 females, mean age: 59 yrs) with HbA1c levels of 9.0% or above were instructed to follow a low-carbohydrate diet (1852 kcal; %CHO:fat:protein = 30:44:20) for 6 months in an outpatient clinic and were followed to assess their HbA1c levels, body mass index and doses of antidiabetic drugs. HbA1c levels decreased sharply from a baseline of 10.9 ± 1.6% to 7.8 ± 1.5% at 3 months and to 7.4 ± 1.4% at 6 months. Body mass index decreased slightly from baseline (23.8 ± 3.3) to 6 months (23.5 ± 3.4). Only two patients dropped out. No adverse effects were observed except for mild constipation. The number of patients on sulfonylureas decreased from 7 at baseline to 2 at 6 months. No patient required inpatient care or insulin therapy. In summary, the 30%-carbohydrate diet over 6 months led to a remarkable reduction in HbA1c levels, even among outpatients with severe type 2 diabetes, without any insulin therapy, hospital care or increase in sulfonylureas. The effectiveness of the diet may be comparable to that of insulin therapy. |
format | Text |
id | pubmed-2690585 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26905852009-06-04 Effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes Haimoto, Hajime Sasakabe, Tae Wakai, Kenji Umegaki, Hiroyuki Nutr Metab (Lond) Brief Communication We previously demonstrated that a loosely restricted 45%-carbohydrate diet led to greater reduction in hemoglobin A1c (HbA1c) compared to high-carbohydrate diets in outpatients with mild type 2 diabetes (mean HbA1c level: 7.4%) over 2 years. To determine whether good glycemic control can be achieved with a 30%-carbohydrate diet in severe type 2 diabetes, 33 outpatients (15 males, 18 females, mean age: 59 yrs) with HbA1c levels of 9.0% or above were instructed to follow a low-carbohydrate diet (1852 kcal; %CHO:fat:protein = 30:44:20) for 6 months in an outpatient clinic and were followed to assess their HbA1c levels, body mass index and doses of antidiabetic drugs. HbA1c levels decreased sharply from a baseline of 10.9 ± 1.6% to 7.8 ± 1.5% at 3 months and to 7.4 ± 1.4% at 6 months. Body mass index decreased slightly from baseline (23.8 ± 3.3) to 6 months (23.5 ± 3.4). Only two patients dropped out. No adverse effects were observed except for mild constipation. The number of patients on sulfonylureas decreased from 7 at baseline to 2 at 6 months. No patient required inpatient care or insulin therapy. In summary, the 30%-carbohydrate diet over 6 months led to a remarkable reduction in HbA1c levels, even among outpatients with severe type 2 diabetes, without any insulin therapy, hospital care or increase in sulfonylureas. The effectiveness of the diet may be comparable to that of insulin therapy. BioMed Central 2009-05-06 /pmc/articles/PMC2690585/ /pubmed/19419563 http://dx.doi.org/10.1186/1743-7075-6-21 Text en Copyright © 2009 Haimoto et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Communication Haimoto, Hajime Sasakabe, Tae Wakai, Kenji Umegaki, Hiroyuki Effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes |
title | Effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes |
title_full | Effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes |
title_fullStr | Effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes |
title_full_unstemmed | Effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes |
title_short | Effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes |
title_sort | effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690585/ https://www.ncbi.nlm.nih.gov/pubmed/19419563 http://dx.doi.org/10.1186/1743-7075-6-21 |
work_keys_str_mv | AT haimotohajime effectsofalowcarbohydratedietonglycemiccontrolinoutpatientswithseveretype2diabetes AT sasakabetae effectsofalowcarbohydratedietonglycemiccontrolinoutpatientswithseveretype2diabetes AT wakaikenji effectsofalowcarbohydratedietonglycemiccontrolinoutpatientswithseveretype2diabetes AT umegakihiroyuki effectsofalowcarbohydratedietonglycemiccontrolinoutpatientswithseveretype2diabetes |